📗 Cite This Artifact
OPALIN — Oligodendrocyte Myelin Membrane Protein
OPALIN — Oligodendrocyte Myelin Membrane Protein
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">OPALIN — Oligodendrocyte Myelin Membrane Protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">MBP</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">PLP</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">OPALIN</td>
<td>High</td>
</tr>
<tr>
<td class="label">MOG</td>
<td>Low</td>
</tr>
<tr>
<td class="label">CNP</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
OPALIN (Oligodendrocyte Myelin Membrane Protein, also known as Trophinin or S100Beta-like protein) is a membrane protein specifically and highly expressed in oligodendrocytes and the myelin sheath within the central nervous system. Located on chromosome 10q22.2, this gene encodes a protein that represents one of the most abundant myelin-specific proteins in the central nervous system, second only to myelin basic protein and proteolipid protein in abundance.
OPALIN — Oligodendrocyte Myelin Membrane Protein
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">OPALIN — Oligodendrocyte Myelin Membrane Protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">MBP</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">PLP</td>
<td>Very high</td>
</tr>
<tr>
<td class="label">OPALIN</td>
<td>High</td>
</tr>
<tr>
<td class="label">MOG</td>
<td>Low</td>
</tr>
<tr>
<td class="label">CNP</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
OPALIN (Oligodendrocyte Myelin Membrane Protein, also known as Trophinin or S100Beta-like protein) is a membrane protein specifically and highly expressed in oligodendrocytes and the myelin sheath within the central nervous system. Located on chromosome 10q22.2, this gene encodes a protein that represents one of the most abundant myelin-specific proteins in the central nervous system, second only to myelin basic protein and proteolipid protein in abundance.
OPALIN serves as a critical marker of mature oligodendrocytes and plays essential roles in myelin formation, stability, and maintenance. Its expression is tightly regulated during development, with low levels in oligodendrocyte precursor cells and dramatic upregulation as cells differentiate into mature, myelinating oligodendrocytes. This protein has garnered significant research attention due to its relevance to demyelinating diseases such as multiple sclerosis, and its potential as a biomarker for oligodendrocyte dysfunction.
Gene and Protein Structure
Gene Organization
The OPALIN gene is located on chromosome 10q22.2 and encodes a protein with distinct structural features. The gene structure consists of multiple exons that undergo alternative splicing to generate distinct isoforms. The genomic organization reflects a relatively compact gene with regulatory elements that drive oligodendrocyte-specific expression.
Protein Domain Architecture
The OPALIN protein contains several specialized structural features:
- N-terminal region: Contains a signal peptide sequence that targets the protein to the secretory pathway
- Extracellular domain: The majority of the protein is extracellular, with potential N-glycosylation sites
- Single transmembrane domain: A hydrophobic transmembrane region anchors the protein in the membrane
- C-terminal intracellular tail: A short cytoplasmic domain that may participate in signaling
The protein has a molecular weight of approximately 55-60 kDa and is heavily modified by glycosylation, which affects its electrophoretic mobility and potentially its function.
Post-Translational Modifications
OPALIN undergoes several post-translational modifications:
Splice Variants
Multiple OPALIN isoforms have been described:
- Full-length isoform: The predominant form in mature oligodendrocytes
- Alternative splice variants: Less abundant isoforms with potential distinct functions
- Proteolytically processed forms: Generated by proteolytic cleavage
Cellular Functions
Myelin Formation
OPALIN plays multiple roles in myelin biogenesis[@yoshikawa2008]:
Oligodendrocyte Maturation
OPALIN serves as a marker and functional component of mature oligodendrocytes[@emery2010]:
- Differentiation marker: Expressed highly in mature, post-mitotic oligodendrocytes
- Functional maturation: Required for proper oligodendrocyte functional maturation
- Process extension: Associated with the formation of myelin sheets
- Myelination capacity: Correlates with the ability to form multilayered myelin
Membrane Organization
Within the myelin sheath, OPALIN likely functions in:
- Lipid organization: Contributes to myelin lipid composition and organization
- Protein partitioning: Distributed in specific myelin compartments
- Node of Ranvier localization: Found at paranodal regions adjacent to nodes
- Protein complexes: May form part of larger protein assemblies
Role in the Central Nervous System
Oligodendrocyte Biology
OPALIN is central to understanding oligodendrocyte function[@nave2010]:
Oligodendrocyte Development:
- Oligodendrocyte precursor cells (OPCs) arise from the subventricular zone
- Precursors proliferate and migrate throughout the white matter
- Upon differentiation, they upregulate OPALIN and other myelin genes
- Mature oligodendrocytes extend processes that wrap around axons
- Each oligodendrocyte can myelinate multiple axons (up to 40-60)
- Myelin segments are organized into internodes separated by nodes of Ranvier
- Myelin provides electrical insulation and supports axon metabolic functions
- OPALIN is incorporated throughout the myelin sheath
Regional Expression
OPALIN is expressed throughout CNS white matter:
- Cerebral white matter: High expression in cortical white matter tracts
- Corpus callosum: Prominent expression in the major commissural tract
- Cerebellar white matter: Robust expression in cerebellar white matter
- Spinal cord: High expression in descending and ascending tracts
- Optic nerve: Strong expression in the optic nerve white matter
Comparison with Other Myelin Proteins
OPALIN differs from other major myelin proteins:
Myelin Biology
Myelin Structure
Myelin is a specialized membrane structure with unique properties[@ritchie2013]:
- Multilayer organization: Multiple wraps of oligodendrocyte membrane
- Compact myelin: Tightly packed lipid layers with embedded proteins
- Node of Ranvier: Regular gaps exposing axonal membrane
- Paranodal loops: Specialized regions contacting axonal membranes
Myelin Functions
Myelin serves critical neurological functions:
Myelin Maintenance
Myelin is metabolically active and requires ongoing maintenance:
- Membrane turnover: Continuous renewal of myelin components
- Lipid synthesis: Active lipid metabolism for myelin lipids
- Protein turnover: Myelin proteins are turned over regularly
- Axonal communication: Bidirectional signaling between myelin and axon
Role in Disease
Multiple Sclerosis
OPALIN is highly relevant to multiple sclerosis research[@compston2008][@lucchinetti2000]:
Demyelination:
- MS is characterized by focal demyelinated lesions in CNS
- OPALIN expression is reduced in active MS lesions
- Loss of OPALIN correlates with oligodendrocyte loss
- Demyelination leads to conduction block and neurological deficits
- Early MS shows attempted remyelination
- OPALIN re-expression in remyelinating oligodendrocytes
- Remyelination is often incomplete or fails in chronic lesions
- Failed remyelination may reflect oligodendrocyte progenitor dysfunction
- OPALIN in cerebrospinal fluid may indicate oligodendrocyte damage
- Serum OPALIN levels are under investigation as biomarkers
- Imaging studies can assess myelin integrity (OPALIN as target)
White Matter Disorders
OPALIN is relevant to various leukodystrophies:
- Metachromatic leukodystrophy: ARSA deficiency affects myelin
- Adrenoleukodystrophy: VLCFA accumulation damages myelin
- Pelizaeus-Merzbacher disease: PLP1 mutations cause dysmyelination
- Vanishing white matter: EIF2B mutations affect myelin stability
Neurodegenerative Diseases
Beyond primary demyelination, OPALIN is affected in:
- Alzheimer's disease: White matter changes include myelin loss
- Parkinson's disease: Some evidence of oligodendrocyte involvement
- Amyotrophic lateral sclerosis: Oligodendrocyte dysfunction contributes
- Normal aging: Age-related myelin changes affect OPALIN expression
Mechanisms of Demyelination
Oligodendrocyte Death
Multiple pathways lead to oligodendrocyte loss[@trapp1998][@barrett2013]:
Immune-Mediated Demyelination
The immune system plays a central role:
- T-cell mediated: CD4+ and CD8+ T cells target myelin
- B-cell involvement: Antibodies against myelin proteins
- Microglial activation: Resident immune cells are activated
- Complement activation: Membrane attack complex formation
Metabolic Dysfunction
Oligodendrocytes are vulnerable to metabolic stress:
- Energy failure: Mitochondrial dysfunction affects oligodendrocytes
- Oxidative stress: High iron content makes them vulnerable
- Excitotoxicity: Glutamate receptor-mediated injury
- Viral infection: Potential role in MS pathogenesis
Remyelination
Biology of Remyelination
Remyelination is the process of restoring myelin to demyelinated axons[@frank2014]:
- OPC activation: Oligodendrocyte precursors are activated
- Proliferation: OPCs proliferate in response to demyelination
- Differentiation: Cells differentiate into new oligodendrocytes
- Myelination: New myelin sheaths are formed on denuded axons
Factors Affecting Remyelination
Remyelination efficiency depends on:
Therapeutic Implications
Understanding OPALIN informs therapeutic strategies:
- OPC activation: Growth factors that stimulate OPCs
- Differentiation enhancers: Compounds promoting oligodendrocyte differentiation
- Anti-inflammatory agents: Reducing inflammation that blocks repair
- Remyelinationpromoting antibodies: Anti-LINGO1 and similar approaches
Research Models
Cellular Models
- Primary oligodendrocytes: Culture of oligodendrocyte lineage cells
- OPC cultures: Oligodendrocyte precursor cell models
- iPSC-derived oligodendrocytes: Patient-derived cells
- Cell lines: Immortalized oligodendrocyte cell lines
Findings from cellular models:
- OPALIN expression correlates with differentiation state
- Cytokines regulate OPALIN expression
- Growth factors modulate OPALIN levels
Animal Models
- Cuprizone model: Toxic demyelination and remyelination
- EAE model: Immune-mediated demyelination
- Transgenic models: Genetic manipulation of OPALIN
- Knockout models: OPALIN-deficient mice
Animal model findings:
- OPALIN is essential for proper myelination
- Deletion causes hypomyelination
- Some redundancy with other myelin proteins
Human Studies
- Postmortem brain: MS lesion analysis
- MRI studies: Myelin imaging
- CSF biomarkers: OPALIN measurement in cerebrospinal fluid
- iPSC studies: Patient-derived oligodendrocyte models
Clinical Features of Demyelination
Symptoms
Demyelination causes various neurological symptoms:
- Motor deficits: Weakness, spasticity, gait disturbance
- Sensory changes: Numbness, paresthesias
- Visual loss: Optic neuritis affecting vision
- Coordination problems: Ataxia, dizziness
- Fatigue: Excessive tiredness
- Cognitive impairment: Memory and attention deficits
Disease Course
Multiple sclerosis has several clinical patterns:
- Primary progressive MS: Progressive from onset
- Clinically isolated syndrome: First demyelinating event
Treatment Approaches
Current MS treatments include:
- Disease-modifying therapies: Reduce relapse rate and disability progression
- Symptomatic treatments: Address specific symptoms
- Rehabilitation: Physical therapy, occupational therapy
- Remyelination strategies: Emerging repair-focused approaches
Cross-References
- [Oligodendrocytes](/cell-types/oligodendrocytes) - Cell type
- [Myelin](/mechanisms/myelin) - Related mechanism
- [Multiple Sclerosis](/diseases/multiple-sclerosis) - Related disease
- [Demyelination](/mechanisms/demyelination) - Related process
- [Remyelination](/mechanisms/remyelination) - Related process
- [White Matter Disorders](/diseases/white-matter-disorders) - Related category
Signal Transduction
Regulation of OPALIN Expression
OPALIN expression is tightly regulated:
Signaling Functions
OPALIN may participate in signaling:
- Receptor interactions: Potential for autocrine or paracrine signaling
- Cell adhesion: May mediate oligodendrocyte-axon interactions
- Signal transduction: Intracellular signaling through its tail
Protein-Protein Interactions
Myelin Protein Network
OPALIN interacts with other myelin components:
Key interactions include:
- Myelin basic protein: In compact myelin layers
- Proteolipid protein: Major structural protein
- Myelin oligodendrocyte glycoprotein: Surface protein
- 2',3'-Cyclic nucleotide 3'-phosphodiesterase: Process formation
Genetic Epidemiology
Population Genetics
- Expression patterns: OPALIN is expressed in all healthy individuals
- Polymorphisms: Genetic variants in OPALIN gene
- Association studies: Limited evidence for disease associations
- Ethnic variation: Few population-specific variants described
Disease Associations
OPALIN-related research focuses on:
- Multiple sclerosis susceptibility
- Response to disease-modifying therapies
- Biomarker potential for disease progression
Future Research Directions
Unresolved Questions
Key questions remain about OPALIN:
Research Priorities
- Remyelination mechanisms: Understanding and enhancing repair
- OPC biology: Better understanding of precursor cells
- Immunomodulation: Controlling harmful inflammation
- Regenerative approaches: Cell-based therapies for myelin repair
Conclusion
OPALIN is a critical myelin-specific protein expressed highly in mature oligodendrocytes within the central nervous system. As one of the most abundant myelin proteins, OPALIN plays essential roles in myelin formation, stability, and maintenance. Its tight developmental regulation and specific expression pattern make it both an important marker of oligodendrocyte maturation and a relevant target for understanding demyelinating diseases.
Key takeaways:
See Also
- [Oligodendrocytes](/cell-types/oligodendrocytes)
- [Myelin](/mechanisms/myelin)
- [Multiple Sclerosis](/diseases/multiple-sclerosis)
- [Demyelination](/mechanisms/demyelination)
- [Remyelination](/mechanisms/remyelination)
- [Genes Index](/genes)
- [Proteins Index](/proteins)
- [Diseases Index](/diseases)
External Links
- [NCBI Gene: OPALIN](https://www.ncbi.nlm.nih.gov/gene/133746)
- [GeneCards: OPALIN](https://www.genecards.org/cgi-bin/carddisp.pl?gene=OPALIN)
- [UniProt: OPALIN](https://www.uniprot.org/uniprot/Q9BZE4)
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/?term=OPALIN+oligodendrocyte+myelin)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-opalin |
| kg_node_id | OPALIN |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-a9e8f51cbb73 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-opalin'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-opalin?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[OPALIN — Oligodendrocyte Myelin Membrane Protein](http://scidex.ai/artifact/wiki-genes-opalin)
http://scidex.ai/artifact/wiki-genes-opalin